Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Matt Orton"


25 mentions found


Signage of Adani Group at Adani Defence and Aerospace booth during the Aero India 2023 at Air Force Station Yelahanka in Bengaluru, India, on Monday, Feb. 13, 2023. India's Adani Group saw shares of its companies plunge Thursday after its billionaire chairman Gautam Adani was indicted in a New York federal court over his alleged involvement in an extensive bribery and fraud operation. The Indian group's flagship firm Adani Enterprises fell 10%, while the company in the eye of the storm Adani Green Energy tanked 17.28%. Adani Energy fell 20%. Adani Power lost 13.81%, Adani Port's share price dropped 10%, while the group's retail arm Adani Wilmar shed 7.87%.
Persons: India's, Gautam Adani, Adani, Sagar Adani, Ranjit Gupta, Rupesh Agarwal, Saurabh Agarwal, Cyril Cabanes, Deepak Malhotra, CDPQ, shortseller, Hindenburg, Raymond James ', Matt Orton Organizations: Adani Defence, Aerospace, Aero, Air Force, India's Adani, Adani Enterprises, Energy, Adani Energy, Adani Power, NSE, Adani Green Energy, Power, Quebec, U.S, Hindenburg Research, CNBC Locations: Bengaluru, India, New York, U.S, Brooklyn
Indian markets have been under pressure in recent weeks, but strategist Matt Orton remains bullish on the country, revealing "one of his favorite" stocks right now. ICIC Bank One stock that stands out to Orton is private bank and financial services player ICICI Bank . "ICICI Bank is one of my favorite picks because it's just a top-quality asset. ICICIBANK-IN YTD mountain Year-to-date shares in ICICI Bank Orton said ICICI is among the three "domestic systemically important banks," or those considered " too big to fail " banks by the Reserve Bank of India. According to FactSet data, of 44 analysts covering the stock, 41 give it a buy or overweight rating, while the remaining three have a hold call.
Persons: Matt Orton, Raymond James, CNBC's, Orton, it's, ICICI Bank Orton, Jefferies Organizations: Raymond James Investment Management, Bombay Stock Exchange, ICICI Bank, India's, Bombay Stock Exchanges, ICICI, Reserve Bank of India Locations: bullish, India, U.S, Mumbai
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailLook for investment themes with bipartisan support under Trump's second term: StrategistMatt Orton of Raymond James Investment Management discusses the sectors that could benefit from the bipartisan support for infrastructure investment and expected fiscal measures.
Persons: Matt Orton, Raymond James Organizations: Raymond James Investment Management
Orton: I see no reason why we can't get post 6000
  + stars: | 2024-10-14 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailOrton: I see no reason why we can't get post 6000Matt Orton, CFA, Chief Market Strategist at Raymond James Investment Management, discusses the upcoming earnings season and emphasizes the concept of "dispersion," where not all companies will perform equally.
Persons: Matt Orton Organizations: CFA, Chief, Raymond James Investment Management
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWill see a 'gradual cutting pace' from the Federal Reserve, strategist saysMatt Orton, chief market strategist at Raymond James Investment Management, discusses the impact of the Federal Reserve's latest interest rate decision and the outlook for monetary policy.
Persons: Matt Orton Organizations: Federal Reserve, Raymond James Investment Management
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMarket is 'getting ahead of itself' by pricing in aggressive cuts, says Raymond James' OrtonMatt Orton, chief market strategist at Raymond James Investment Management, joins CNBC's 'The Exchange' to discuss why he's not seeing weakness in the labor market, why this means the market may not be pricing in rate cuts correctly, and more.
Persons: Raymond James, Orton Matt Orton Organizations: Raymond James Investment Management
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNo conclusive evidence that the U.S. is 'rapidly slipping' into a recession: StrategistMatt Orton, chief market strategist at Raymond James Investment Management, discusses the Wall Street selloff and says it's not something investors should be concerned about.
Persons: Matt Orton, it's Organizations: Raymond James Investment Management
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailStick with momentum winners in this market, says Raymond James' Matt OrtonMatt Orton, chief market strategist at Raymond James Investment Management, joins 'The Exchange' to discuss why he believes in sticking with mega-cap stocks, a bullish case on big banks, and more.
Persons: Raymond James, Matt Orton Matt Orton Organizations: Raymond James Investment Management
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEarnings remain 'key catalyst' that will keep bull market going, says Raymond James' Matt OrtonMatt Orton, chief market strategist at Raymond James Investment Management, joins CNBC's 'The Exchange' to discuss what he's paying attention to this earnings season, small cap winners, and more.
Persons: Raymond James, Matt Orton Matt Orton Organizations: Raymond James Investment Management
Several investors have been looking favorably at Japanese stocks in the past few months, and market strategist Matt Orton is no exception. "Japan overall, has been a fantastic market ... Japan was the top performer within the Asian equity market complex," the chief market strategist at asset management firm Raymond James Investment Management told CNBC's " Squawk Box Asia " on April 1. One stock that stands out to Orton is Sumitomo Mitsui Financial Group . Of the 14 analysts covering the stock, 10 give it a buy or overweight rating, while four have a hold rating, according to FactSet data. Analysts' average price target for the stock is 9,537.50 Japanese yen ($62.89), giving it around 11% potential upside.
Persons: Matt Orton, Raymond James, CNBC's, levered, they've, Orton Organizations: Raymond James Investment Management, Japan's Nikkei, Tokyo Exchange, Orton, Sumitomo Mitsui Financial Group, Sumitomo Locations: Japan, Tokyo, Indonesia, India, Vietnam, Philippines
Market strategist Matt Orton sees promise in small-cap stocks this year, naming four under-the-radar companies he is bullish on right now. Year-to-date, the Russell 2000 , the benchmark for small-cap stocks, has been up nearly 5.2% despite having a tough start to 2024. Small-cap players in the U.S. stand out as "very, very attractive" right now, he said, naming Vertiv Holdings and CyberArk as two companies on his radar. The market strategist remains confident on the stock, noting that "just because it is up, doesn't mean you don't want to own it." CyberArk The market strategist also has his eye on the cybersecurity space.
Persons: Matt Orton, Orton, Raymond James, CNBC's, Russell Organizations: Raymond James Investment Management, Vertiv Holdings, Vertiv Holdings Vertiv Holdings Locations: 2H24, U.S
CNBC Daily Open: Fights in the House of Mouse
  + stars: | 2024-04-02 | by ( Clement Tan | In Clemtan | ) www.cnbc.com   time to read: +2 min
Actors dressed as Walt Disney characters Mickey Mouse (left) and Minnie Mouse (right) perform during a press preview for the "Minnie Besties Bash!" This report is from today's CNBC Daily Open, our new, international markets newsletter. CNBC Daily Open brings investors up to speed on everything they need to know, no matter where they are. Rumbling signs of lifeThe IPO market in the U.S. is showing signs of revival after more than two years. CNBC previously reported that United would pause pilot hiring this spring for the same reason.
Persons: Walt Disney, Mickey Mouse, Minnie Mouse, Minnie Besties, Jerome Powell's, Slack, Matt Orton Organizations: Tokyo Disneyland, CNBC, Dow Jones, Nasdaq, European Commission, United Airlines, Boeing Locations: Tokyo, Urayasu, Japan, U.S
Investors should disregard concerns over high valuations and focus on growth in what is now a "stockpicker's market," according to Matt Orton, chief market strategist at Raymond James Investment Management. The S&P 500 closed out a two-week losing streak on Friday, but Orton told CNBC that stock market gains are broadening and brief pullbacks should be used "opportunistically." Much of the significant rally over the last 18 months has been driven by the so-called "Magnificent 7" megacap tech stocks, but they have begun to diverge. "We're back to a stockpicker's market – idiosyncratic risk is finally being rewarded again and that, to me, is most important. It means that you have the opportunity to diversify your portfolio and actually lean into what works and lean out of what's not," Orton told CNBC's "Squawk Box Europe" on Monday.
Persons: Matt Orton, Orton, Tesla, CNBC's Organizations: Raymond James Investment Management, CNBC, Apple, Microsoft, Nvidia
'We're back to a stock picker's market,' Raymond James says
  + stars: | 2024-03-18 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via Email'We're back to a stock picker's market,' Raymond James saysMatt Orton, chief market strategist at Raymond James Investment Management, says the market has stabilised such that "the fundamentals matter again" and investors can be rewarded for individual stock selection.
Persons: Raymond James, Matt Orton Organizations: Raymond James Investment Management
Investors now expect that the Fed will begin easing back rates in May or June, according to the CME FedWatch Tool. Before the Bell: What does the Fed’s signal that it won’t cut rates in March mean for markets? I think what’s important for the markets themselves is the fact that the Fed has signaled they’re going to cut rates. So, they’re going to cut rates at some point this year, probably May or June is going to be the first cut that we get. There’s a lot of areas where your earnings … start to reaccelerate higher, and that’s a good thing.
Persons: Stocks, Jerome Powell, Bell, Matt Orton, I’ve, We’re, it’s, Matt Egan, Read, Price Organizations: CNN Business, Bell, New York CNN, Investors, Fed, Raymond James Investment Management, The Conference, Conference, Avis Budget Group, Hasbro, Cola, Molson Coors, The, Labor Statistics, Kraft, Heinz, The Commerce Department, National Association of Home Builders, University of Michigan Locations: New York, Wells Fargo
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe S&P 500 is no longer a good barometer for the average stock, strategist saysMatt Orton, chief market strategist at Raymond James Investment Management, discusses the investment outlook and explains why he believes the S&P 500 is no longer a good barometer for the average stock.
Persons: Matt Orton Organizations: Raymond James Investment Management
2023 wasn't a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. But now, Citi believes that "astute investors may find themselves with a trove of rebound opportunities." Citi's top picks in biotech include Biomea Fusion , Alnylam Pharmaceuticals , and Immunovant . Jared Holz, health-care sector strategist at Mizuho Securities Americas, named biotech firm Biogen as one of his top trading ideas for 2024. "Biotech has commanded everyone's attention, but the recovery of many best-in-class medical device companies post the GLP-1 selloff has been remarkable," Orton said.
Persons: There's, Jared Holz, Biogen, Trent, medtech, Matt Orton, Orton Organizations: Citi Global Wealth Investments, U.S . Healthcare, Citi, Biomea, Alnylam Pharmaceuticals, Mizuho Securities Americas, Biogen, medtech, Raymond James Investment Management, Medical, Biotech, Abbott Laboratories Locations: U.S, Alphinity, medtech
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailJapan is the one place investors can be rewarded for leaning into value stocks: Raymond James IMMatt Orton of Raymond James Investment Management says investors "have not missed the rally" in Japanese equities, explaining that there is value to be found in financial and industrial conglomerates.
Persons: Raymond James, Matt Orton Organizations: Japan, Raymond James Investment Management
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWe're at a point where it 'makes sense to start buying the dip', says Raymond James' Matt OrtonAdam Crisafulli, Vital Knowledge founder and Matt Orton, Raymond James chief market strategist, join 'Closing Bell Overtime' to talk the day's market action.
Persons: Raymond James, Matt Orton Adam Crisafulli, Matt Orton Organizations: Vital Knowledge
Matt Orton, chief market strategist at Raymond James Investment Management, was the latest to urge investors to "strategically add" to small-cap stocks right now. Tom Ognar, senior portfolio manager at Allspring Global Investments, said small- and mid-cap stocks look the "most incrementally interesting" among growth stocks. "We're very attuned to the valuation discounts currently being afforded to small- and mid-cap stocks after protracted periods of underperformance relative to large-cap stocks," he said. It screened for the best small-cap stocks to play an economic recovery. RBC Capital Markets also released, in a September note, an updated list of what it called "high conviction" U.S. small-cap growth recommendations.
Persons: Matt Orton, Russell, CNBC's, Orton, Tom Ognar, Ognar, CNBC'S, Valvoline, it's, — CNBC's Michael Bloom Organizations: Raymond James Investment Management, Allspring Global Investments, . Bank of America, Microsystems, Technologies, RBC Capital Markets, Automotive, RBC, Clearwater Analytics, Clearwater, Xenon Pharmaceuticals
Tech giant Alphabet is "the cheapest" of all the mega-cap names, according to Matt Orton, chief market strategist at Raymond James Investment Management. With the U.S. consumer "holding up well," its ad-driven revenues are "incredibly strong," he told CNBC's " Street Signs Asia " on Monday. "That's probably the cheapest by far — the cheapest of all the mega-cap names, and so I think there's a lot of durability to Alphabet," he concluded. Orton said what's "most exciting" about Alphabet is the long-term artificial intelligence opportunity, adding that the tech giant is underappreciated in that regard. Alphabet versus Microsoft Alphabet and Microsoft will be the two long-term winners in AI, according to Orton.
Persons: Matt Orton, CNBC's, Orton, That's, what's Organizations: Raymond James Investment Management, Google, Microsoft Locations: Office360
In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAlphabet has better AI product than anything else on the market: StrategistMatt Orton of Raymond James Investment Management explains why Alphabet is his top pick when it comes to investing in AI.
Persons: Matt Orton, Raymond James Organizations: Raymond James Investment Management
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailThe consumer remains in 'good shape' which will support earnings, strategist saysMatt Orton, chief investment strategist at Raymond James, discusses banking results and why he doesn't think there will be an "earnings apocalypse."
Persons: Matt Orton, Raymond James
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailEarnings season shows consumers still spending despite inflation, says Raymond James’ Matt OrtonG Squared’s Victoria Greene and Raymond James’ Matt Orton, join 'Closing Bell: Overtime' to discuss their takeaways after a big earnings week and what it means for the Fed meeting next week.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailWatch CNBC’s full interview with G Squared’s Victoria Greene and Raymond James’ Matt OrtonG Squared’s Victoria Greene and Raymond James’ Matt Orton, join 'Closing Bell: Overtime' to discuss their takeaways after a big earnings week and what it means for the Fed meeting next week.
Total: 25